These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35324488)

  • 1. Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders.
    Grasing KW; Burnell K; De A
    Behav Pharmacol; 2022 Jun; 33(4):238-248. PubMed ID: 35324488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study.
    Pirtle JL; Hickman MD; Boinpelly VC; Surineni K; Thakur HK; Grasing KW
    Pharmacol Biochem Behav; 2019 May; 180():52-59. PubMed ID: 30811963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.
    Peng XQ; Ashby CR; Spiller K; Li X; Li J; Thomasson N; Millan MJ; Mocaër E; Muńoz C; Gardner EL; Xi ZX
    Neuropharmacology; 2009 Mar; 56(4):752-60. PubMed ID: 19136017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.
    Collins GT; France CP
    Exp Clin Psychopharmacol; 2018 Oct; 26(5):488-496. PubMed ID: 29952618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys.
    Collins GT; Gerak LR; Javors MA; France CP
    J Pharmacol Exp Ther; 2016 Jan; 356(1):85-95. PubMed ID: 26534942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration.
    Anastasio NC; Sholler DJ; Fox RG; Stutz SJ; Merritt CR; Bjork JM; Moeller FG; Cunningham KA
    Neuropharmacology; 2020 May; 168():108009. PubMed ID: 32145488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-HT(2C) receptor agonist lorcaserin reduces cocaine self-administration, reinstatement of cocaine-seeking and cocaine induced locomotor activity.
    Harvey-Lewis C; Li Z; Higgins GA; Fletcher PJ
    Neuropharmacology; 2016 Feb; 101():237-45. PubMed ID: 26427596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (±)VK4-40, a novel dopamine D
    Jordan CJ; He Y; Bi GH; You ZB; Cao J; Xi ZX; Newman AH
    Br J Pharmacol; 2020 Oct; 177(20):4796-4807. PubMed ID: 32851643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lorcaserin on reinstatement of responding previously maintained by cocaine or remifentanil in rhesus monkeys.
    Gerak LR; Collins GT; Maguire DR; France CP
    Exp Clin Psychopharmacol; 2019 Feb; 27(1):78-86. PubMed ID: 30382731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders.
    Collins GT; Gerak LR; France CP
    Neuropharmacology; 2018 Nov; 142():63-71. PubMed ID: 29246856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
    Xi ZX; Newman AH; Gilbert JG; Pak AC; Peng XQ; Ashby CR; Gitajn L; Gardner EL
    Neuropsychopharmacology; 2006 Jul; 31(7):1393-405. PubMed ID: 16205781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated 7-Day Treatment with the 5-HT
    Banks ML; Negus SS
    Neuropsychopharmacology; 2017 Apr; 42(5):1082-1092. PubMed ID: 27857126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats.
    Gannon BM; Sulima A; Rice KC; Collins GT
    J Pharmacol Exp Ther; 2018 Mar; 364(2):359-366. PubMed ID: 29217539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
    Xi ZX; Yang Z; Li SJ; Li X; Dillon C; Peng XQ; Spiller K; Gardner EL
    Neuropharmacology; 2007 Nov; 53(6):771-82. PubMed ID: 17888459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats.
    Neelakantan H; Holliday ED; Fox RG; Stutz SJ; Comer SD; Haney M; Anastasio NC; Moeller FG; Cunningham KA
    ACS Chem Neurosci; 2017 May; 8(5):1065-1073. PubMed ID: 28107783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats.
    Xi ZX; Gilbert JG; Pak AC; Ashby CR; Heidbreder CA; Gardner EL
    Eur J Neurosci; 2005 Jun; 21(12):3427-38. PubMed ID: 16026480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D1 and D3 receptor interactions in cocaine reward and seeking in rats.
    Galaj E; Harding W; Ranaldi R
    Psychopharmacology (Berl); 2016 Dec; 233(23-24):3881-3890. PubMed ID: 27582181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats.
    Song R; Bi GH; Zhang HY; Yang RF; Gardner EL; Li J; Xi ZX
    Neuropharmacology; 2014 Feb; 77():398-405. PubMed ID: 24176392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.